Specific glial functions contribute to schizophrenia susceptibility.

Schizophrenia is a highly polygenic brain disorder. The main hypothesis for disease etiology in schizophrenia primarily focuses on the role of dysfunctional synaptic transmission. Previous studies have therefore directed their investigations toward the role of neuronal dysfunction. However, recent studies have shown that apart from neurons, glial cells also play a major role in synaptic transmission. Therefore, we investigated the potential causal involvement of the 3 principle glial cell lineages in risk to schizophrenia. We performed a functional gene set analysis to test for the combined effects of genetic variants in glial type-specific genes for association with schizophrenia. We used genome-wide association data from the largest schizophrenia sample to date, including 13 689 cases and 18 226 healthy controls. Our results show that astrocyte and oligodendrocyte gene sets, but not microglia gene sets, are associated with an increased risk for schizophrenia. The astrocyte and oligodendrocyte findings are related to astrocyte signaling at the synapse, myelin membrane integrity, glial development, and epigenetic control. Together, these results show that genetic alterations underlying specific glial cell type functions increase susceptibility to schizophrenia and provide evidence that the neuronal hypothesis of schizophrenia should be extended to include the role of glia.

[1]  Natasa Kovacevic,et al.  Oligodendrocyte genes, white matter tract integrity, and cognition in schizophrenia. , 2013, Cerebral cortex.

[2]  H. Kettenmann,et al.  Release of gliotransmitters and transmitter receptors in astrocytes , 2013 .

[3]  Simon C. Potter,et al.  Genome-wide Association Analysis Identifies 14 New Risk Loci for Schizophrenia , 2013, Nature Genetics.

[4]  Janet B W Williams Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[5]  T. Sakurai,et al.  Roles of glial cells in schizophrenia: Possible targets for therapeutic approaches , 2013, Neurobiology of Disease.

[6]  E. Smeraldi,et al.  Cognitive dysfunction and glutamate reuptake: Effect of EAAT2 polymorphism in schizophrenia , 2012, Neuroscience Letters.

[7]  Jason H. Moore,et al.  Pathway analysis of genomic data: concepts, methods, and prospects for future development. , 2012, Trends in genetics : TIG.

[8]  S. Löwel,et al.  Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet , 2012, Nature Medicine.

[9]  M. Kreft,et al.  Rab4 and Rab5 GTPase are required for directional mobility of endocytic vesicles in astrocytes , 2012, Glia.

[10]  J. Kleinman,et al.  Spatiotemporal transcriptome of the human brain , 2011, Nature.

[11]  M. Swami New from NPG: Genome-wide association study identifies five new schizophrenia loci , 2011, Nature Medicine.

[12]  M C O'Donovan,et al.  Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia , 2011, Molecular Psychiatry.

[13]  Debra L. Fulton,et al.  Towards resolving the transcription factor network controlling myelin gene expression , 2011, Nucleic acids research.

[14]  M. Gill,et al.  Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility , 2011, Molecular Psychiatry.

[15]  K. Nave,et al.  Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models , 2011, Journal of Lipid Research.

[16]  P. Penzes,et al.  Dendritic spine pathology in neuropsychiatric disorders , 2011, Nature Neuroscience.

[17]  T. Woo,et al.  Oxidative stress in schizophrenia: An integrated approach , 2011, Neuroscience & Biobehavioral Reviews.

[18]  K. Davis,et al.  Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia , 2011, Progress in Neurobiology.

[19]  K. Okanoya,et al.  Evaluation of Pax6 Mutant Rat as a Model for Autism , 2010, Neuroscience Research.

[20]  Ben A. Barres,et al.  Regulation of synaptic connectivity by glia , 2010, Nature.

[21]  M. Graeber Changing Face of Microglia , 2010, Science.

[22]  A. Hayashi‐Takagi,et al.  Disturbed synaptic connectivity in schizophrenia: Convergence of genetic risk factors during neurodevelopment , 2010, Brain Research Bulletin.

[23]  Ayellet V. Segrè,et al.  Hundreds of variants clustered in genomic loci and biological pathways affect human height , 2010, Nature.

[24]  Thomas W. Mühleisen,et al.  Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples , 2010, Molecular Psychiatry.

[25]  Gonçalo R. Abecasis,et al.  Functional Gene Group Analysis Reveals a Role of Synaptic Heterotrimeric G Proteins in Cognitive Ability , 2010, American journal of human genetics.

[26]  A. Smit,et al.  SCAP is required for timely and proper myelin membrane synthesis , 2009, Proceedings of the National Academy of Sciences.

[27]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[28]  Manuel A. R. Ferreira,et al.  Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. , 2009, American journal of human genetics.

[29]  Lise Getoor,et al.  Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia , 2009, Schizophrenia Research.

[30]  B. Maher Personal genomes: The case of the missing heritability , 2008, Nature.

[31]  R. Boellaard,et al.  Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography Study , 2008, Biological Psychiatry.

[32]  N. Schork,et al.  Pathway analysis of seven common diseases assessed by genome-wide association. , 2008, Genomics.

[33]  S. Horvath,et al.  Functional organization of the transcriptome in human brain , 2008, Nature Neuroscience.

[34]  M. Fukuda,et al.  Membrane traffic in the secretory pathway , 2008, Cellular and Molecular Life Sciences.

[35]  R. Fields,et al.  White matter in learning, cognition and psychiatric disorders , 2008, Trends in Neurosciences.

[36]  Peter M Visscher,et al.  Sizing up human height variation , 2008, Nature Genetics.

[37]  Y. Xing,et al.  A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.

[38]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[39]  M. Daly,et al.  Guilt beyond a reasonable doubt , 2007, Nature Genetics.

[40]  H. Gendelman,et al.  Genomic and proteomic microglial profiling: pathways for neuroprotective inflammatory responses following nerve fragment clearance and activation , 2007, Journal of neurochemistry.

[41]  Gavin Sherlock,et al.  The Stanford Microarray Database: implementation of new analysis tools and open source release of software , 2002, Nucleic Acids Res..

[42]  Heri Ramampiaro,et al.  GeneTools – application for functional annotation and statistical hypothesis testing , 2006, BMC Bioinformatics.

[43]  G. Knott,et al.  Plasticity of Astrocytic Coverage and Glutamate Transporter Expression in Adult Mouse Cortex , 2006, PLoS biology.

[44]  H. Anisman,et al.  Bombesin Receptors as a Novel Anti-Anxiety Therapeutic Target: BB1 Receptor Actions on Anxiety through Alterations of Serotonin Activity , 2006, The Journal of Neuroscience.

[45]  Patrick F Sullivan,et al.  Recurrence risks for schizophrenia in a Swedish National Cohort , 2006, Psychological Medicine.

[46]  Carl-Fredrik Westin,et al.  The Application of DTI to Investigate White Matter Abnormalities in Schizophrenia , 2005, Annals of the New York Academy of Sciences.

[47]  J. Meldolesi,et al.  Astrocytes, from brain glue to communication elements: the revolution continues , 2005, Nature Reviews Neuroscience.

[48]  P. Gebicke-haerter,et al.  Microarrays and expression profiling in microglia research and in inflammatory brain disorders , 2005, Journal of neuroscience research.

[49]  Bing Zhang,et al.  WebGestalt: an integrated system for exploring gene sets in various biological contexts , 2005, Nucleic Acids Res..

[50]  Kazuo Yamada,et al.  DNA Methylation Status of SOX10 Correlates with Its Downregulation and Oligodendrocyte Dysfunction in Schizophrenia , 2005, The Journal of Neuroscience.

[51]  Paul J. Harrison,et al.  Schizophrenia: a genetic disorder of the synapse? , 2005, British medical journal.

[52]  M. Figiel,et al.  Endothelins Negatively Regulate Glial Glutamate Transporter Expression , 2004, Brain pathology.

[53]  Atsushi Miyawaki,et al.  PKC Signaling Mediates Global Enhancement of Excitatory Synaptogenesis in Neurons Triggered by Local Contact with Astrocytes , 2004, Neuron.

[54]  J. Glowinski,et al.  Endothelins regulate astrocyte gap junctions in rat hippocampal slices , 2004, The European journal of neuroscience.

[55]  R. Schlapbach,et al.  TGFβ directs gene expression of activated microglia to an anti‐inflammatory phenotype strongly focusing on chemokine genes and cell migratory genes , 2003, Glia.

[56]  M. Verheijen,et al.  Local regulation of fat metabolism in peripheral nerves. , 2003, Genes & development.

[57]  Vahram Haroutunian,et al.  Global expression-profiling studies and oligodendrocyte dysfunction in schizophrenia and bipolar disorder , 2003, The Lancet.

[58]  S. Ojeda,et al.  Neuron-to-Glia Signaling Mediated by Excitatory Amino Acid Receptors Regulates ErbB Receptor Function in Astroglial Cells of the Neuroendocrine Brain , 2003, The Journal of Neuroscience.

[59]  L. Manuelidis,et al.  Unique inflammatory RNA profiles of microglia in Creutzfeldt–Jakob disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[60]  P. Ricciardi-Castagnoli,et al.  Granulocyte-Macrophage Colony-Stimulating Factor Induces an Expression Program in Neonatal Microglia That Primes Them for Antigen Presentation1 , 2002, The Journal of Immunology.

[61]  M. Götz,et al.  Glial cells generate neurons: the role of the transcription factor Pax6 , 2002, Nature Neuroscience.

[62]  Y. Humeau,et al.  A Rho-related GTPase Is Involved in Ca2+-dependent Neurotransmitter Exocytosis* , 2000, The Journal of Biological Chemistry.

[63]  S. Thompson Advances in experimental medicine and biology , 1996 .

[64]  N. Andreasen,et al.  Symptoms, signs, and diagnosis of schizophrenia , 1995, The Lancet.

[65]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[66]  J. Bixby,et al.  N-cadherin and integrins: Two receptor systems that mediate neuronal process outgrowth on astrocyte surfaces , 1988, Neuron.

[67]  P. Seeman,et al.  Brain receptors for antipsychotic drugs and dopamine: direct binding assays. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[68]  Mirko Santello,et al.  Gliotransmission and the tripartite synapse. , 2012, Advances in experimental medicine and biology.

[69]  T. Insel Rethinking schizophrenia , 2010, Nature.

[70]  Rüdiger Klein,et al.  Bidirectional modulation of synaptic functions by Eph/ephrin signaling , 2009, Nature Neuroscience.

[71]  K. Davies,et al.  SNARE proteins and schizophrenia: linking synaptic and neurodevelopmental hypotheses. , 2008, Acta biochimica Polonica.

[72]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[73]  L. Reichardt N-Cadherin and integrins: two receptor systems that mediate neuronal process outgrowth on astrocyte surfaces. , 2008, Neuron.

[74]  K. Mossman The Wellcome Trust Case Control Consortium, U.K. , 2008 .